You specifically said that the FDA never allowed the trial to resume screening, and even now (in your post), you state that the first action the FDA took was to "issue the partial hold that blocked screening new patients."
Then of course, in February 2017, the company announced that the FDA had lifted the halt that halted the screening of new patients.
It is YOUR THEORY (and not a hard fact) that the FDA did not let them screen new patients, despite the HARD FACT that the FDA lifted the halt allowing them to screen new patients.
You have no HARD PROOF that your theory is a fact... you just offer your statement that it is a "hard fact."
You may think that your THEORY is the only logical conclusion to come to, but it really does have an obvious flaw.
It simply doesn’t make sense that the FDA would lift the halt to screen new patients, and then not let the trial (should they have chosen to do so) screen new patients.
You know, we've had this same conversation countless times over the years, so your theory is not new to me (and others that have been here for some time), and my response is likely not new to you either.
Market Data 
Markets 
AI
